ScholarIQanswers from OpenAlex & ORCID
Edmund Juszczak
ResearcherPublications, citations & collaboration network
Edmund Juszczak is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Edmund Juszczak have?
ScholarIQindexed works
Edmund Juszczak has 253 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Edmund Juszczak have?
ScholarIQcitation count
Edmund Juszczak has 28,919 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Edmund Juszczak?
ScholarIQh-index
Edmund Juszczak has an h-index of 64 in OpenAlex.
What is the i10-index of Edmund Juszczak?
ScholarIQi10-index
Edmund Juszczak has an i10-index of 126 in OpenAlex.
What is the ORCID of Edmund Juszczak?
ScholarIQorcid
The ORCID for Edmund Juszczak is on the source record.
What is the OpenAlex record for Edmund Juszczak?
ScholarIQopenalex
The OpenAlex for Edmund Juszczak is on the source record.
What are the most-cited papers on Edmund Juszczak?
ScholarIQmost cited works
Dexamethasone in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group, Peter Horby, Wei Shen Lim, Jonathan Emberson, Marion Mafham, Jennifer Bell, Louise Linsell, Natalie Staplin, Christopher E. Brightling, Andrew Ustianowski, Einas Elmahi, Benjamin Prudon, Christopher Green, Timothy Felton, David Chadwick, Rege, Kanchan, Chris Fegan, Lucy C. Chappell, Saul N. Faust, Thomas Jaki, Katie Jeffery, Alan Montgomery, Kathy Rowan, Edmund Juszczak, J. Kenneth Baillie, Richard Haynes, Martin Landray
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Peter Horby, Wei Shen Lim, Jonathan Emberson, Marion Mafham, Jennifer Bell, Louise Linsell, Natalie Staplin, Christopher Brightling, Andrew Ustianowski, Einas Elmahi, Benjamin Prudon, Christopher Green, Timothy Felton, David Chadwick, Kanchan Rege, Chris Fegan, Lucy C. Chappell, Saul N. Faust, Thomas Jaki, Katie Jeffery, Alan Montgomery, Kathy Rowan, Edmund Juszczak, J. Kenneth Baillie, Richard Haynes, Martin Landray, RECOVERY Collaborative Group
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard, Rupert McShane, James Lindesay, Craig Ritchie, Ashley Baldwin, Robert Barber, Alistair Burns, Tom Dening, David M. Findlay, Clive Holmes, Alan Hughes, Robin Jacoby, Rob Jones, Roy Jones, Ian G. McKeith, Ajay Macharouthu, John T. O’Brien, Peter Passmore, Bart Sheehan, Edmund Juszczak, Cornelius Katona, Robert K. Hills, Martín Knapp, Clive Ballard, Richard G. Brown, Sube Banerjee, Caroline Onions, Mary Griffin, Jessica Adams, Richard Gray, Tony Johnson, Peter Bentham, Patrick Phillips
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Marion Mafham, Jennifer Bell, Louise Linsell, Natalie Staplin, Jonathan Emberson, Adrian Palfreeman, Jason Raw, Einas Elmahi, Benjamin Prudon, Christopher Green, Simon Carley, David Chadwick, Matthew Davies, Matt P. Wise, J. Kenneth Baillie, Lucy C. Chappell, Saul N. Faust, Thomas Jaki, Katie Jefferey, Wei Shen Lim, Alan Montgomery, Kathy Rowan, Edmund Juszczak, Richard Haynes, Martin Landray
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
Clive Ballard, Maria Luisa Hanney, Megan Theodoulou, Simon Douglas, Rupert McShane, Katja Kossakowski, Randeep Gill, Edmund Juszczak, Ly‐Mee Yu, Robin Jacoby